21 transactions in one company, from January 3, 2025 to January 21, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | IKT | 21 | — | — |
21 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 45,000 | $0.00 | —? | 45,000derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 45,000 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 35,000 | $0.00 | —? | 35,000derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 35,000 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 20,834 | $0.00 | —? | 20,834derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 20,834 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 16,667 | $0.00 | —? | 16,667derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 16,667 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 3,643 | $0.00 | —? | 3,643derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 3,643 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 3,643 | $0.00 | —? | 3,643derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 3,643 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 3,643 | $0.00 | —? | 3,643derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 3,643 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 3,643 | $0.00 | —? | 3,643derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 3,643 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | AAward | 3,643 | $0.00 | —? | 3,643derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 21 | DReturned to issuer | 3,643 | $0.00 | —? | 0derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 3 | AAward | 4,059,744 | $0.00 | —? | 4,059,744derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 3 | AAward | 2,207,671 | $0.00 | —? | 2,207,671derivatives |
| Inhibikase Therapeutics, Inc. | IKT | Milton H. WernerCEODERIV | Jan 3 | AAward | 5,315,056 | $0.00 | —? | 5,315,056derivatives |